These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 31495299)
21. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease. Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256 [TBL] [Abstract][Full Text] [Related]
22. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test. Kang K; Ko PW; Jin M; Suk K; Lee HW J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892 [TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review. Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681 [TBL] [Abstract][Full Text] [Related]
24. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes. Jurjević I; Miyajima M; Ogino I; Akiba C; Nakajima M; Kondo A; Kikkawa M; Kanai M; Hattori N; Arai H J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315 [TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis. Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988 [TBL] [Abstract][Full Text] [Related]
26. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study. Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350 [TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders. Hovd MH; Mariussen E; Uggerud H; Lashkarivand A; Christensen H; Ringstad G; Eide PK Fluids Barriers CNS; 2022 Jul; 19(1):55. PubMed ID: 35778719 [TBL] [Abstract][Full Text] [Related]
29. Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients. Hasan-Olive MM; Enger R; Hansson HA; Nagelhus EA; Eide PK Fluids Barriers CNS; 2019 Dec; 16(1):39. PubMed ID: 31849332 [TBL] [Abstract][Full Text] [Related]
30. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease. Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676 [TBL] [Abstract][Full Text] [Related]
31. Biomechanical effects of hyper-dynamic cerebrospinal fluid flow through the cerebral aqueduct in idiopathic normal pressure hydrocephalus patients. Maeda S; Otani T; Yamada S; Watanabe Y; Ilik SY; Wada S J Biomech; 2023 Jul; 156():111671. PubMed ID: 37327645 [TBL] [Abstract][Full Text] [Related]
32. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. Hiraoka K; Narita W; Kikuchi H; Baba T; Kanno S; Iizuka O; Tashiro M; Furumoto S; Okamura N; Furukawa K; Arai H; Iwata R; Mori E; Yanai K J Neurol Sci; 2015 Sep; 356(1-2):124-8. PubMed ID: 26095458 [TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid and blood flow patterns in idiopathic normal pressure hydrocephalus. Qvarlander S; Ambarki K; Wåhlin A; Jacobsson J; Birgander R; Malm J; Eklund A Acta Neurol Scand; 2017 May; 135(5):576-584. PubMed ID: 27388230 [TBL] [Abstract][Full Text] [Related]
34. Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus. Yang Y; He J; Wang Y; Wang C; Tan C; Liao J; Tong L; Xiao G J Neuroinflammation; 2022 Jun; 19(1):156. PubMed ID: 35715859 [TBL] [Abstract][Full Text] [Related]
35. Hydrocephalus due to villous hypertrophy of the choroid plexus in the lateral ventricles. Case report. Hirano H; Hirahara K; Asakura T; Shimozuru T; Kadota K; Kasamo S; Shimohonji M; Kimotsuki K; Goto M J Neurosurg; 1994 Feb; 80(2):321-3. PubMed ID: 8283272 [TBL] [Abstract][Full Text] [Related]
36. The Pathogenesis Based on the Glymphatic System, Diagnosis, and Treatment of Idiopathic Normal Pressure Hydrocephalus. Tan C; Wang X; Wang Y; Wang C; Tang Z; Zhang Z; Liu J; Xiao G Clin Interv Aging; 2021; 16():139-153. PubMed ID: 33488070 [TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease. Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628 [TBL] [Abstract][Full Text] [Related]
38. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus. Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317 [TBL] [Abstract][Full Text] [Related]
39. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897 [TBL] [Abstract][Full Text] [Related]